Werth Peter J. 4
4 · Cingulate Inc. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Cingulate (CING) Director Peter J. Werth Buys Shares
What Happened
Peter J. Werth, a director of Cingulate Inc. (CING), purchased 19,455 common shares at $5.04 each for a total of $98,053 on February 6, 2026. On the same date he also acquired 15,564 derivative securities at $0.10 each (total $1,556). Both transactions are reported as purchases (transaction code P) and were part of a private placement disclosed by the company.
Key Details
- Transaction date: 2026-02-06; Filing date: 2026-02-10 (filed after the 2-business-day deadline — one business day late).
- Common shares: 19,455 shares @ $5.04 = $98,053.
- Derivative securities: 15,564 units @ $0.10 = $1,556 (reported as derivative acquisition).
- Shares owned after the transactions: Not disclosed in this Form 4.
- Footnotes of note:
- F1: Common stock and warrants were acquired in the issuer’s private placement (see Form 8‑K filed Jan 28, 2026).
- F3: The warrant(s) are exercisable only after the issuer obtains stockholder approval required by Nasdaq rules; expiration is 36 months after exercise.
- F2: Reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
Context
The derivative securities appear to be warrants tied to the private placement; they are not immediately exercisable and require shareholder approval per Nasdaq rules, so they do not immediately increase share count. Director purchases are often watched by investors as a potential positive signal, but this report is purely factual and does not state any motive.
Insider Transaction Report
- Purchase
Common Stock
[F1][F2]2026-02-06$5.04/sh+19,455$98,053→ 117,449 total(indirect: By LLC) - Purchase
Warrant to Purchase Common Stock
[F1][F3][F2]2026-02-06$0.10/sh+15,564$1,556→ 15,564 total(indirect: By LLC)Exercise: $5.04→ Common Stock (15,564 underlying)
- 92
Common Stock
Footnotes (3)
- [F1]Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026.
- [F2]Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F3]The warrant is exercisable upon the Issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules. The expiration date of the warrant is 36 months after the exercise date.